Results 91 to 100 of about 29,384 (211)
Synergistic effects of sulbactam in multi-drug-resistant Acinetobacter baumannii [PDF]
Acinetobacter baumannii is a frequently isolated etiologic agent of nosocomial infections, especially in intensive care units. With the increase in multi-drug resistance of A.
Gunay Ertem +6 more
core
AMPICILLIN SULBACTAM AND CEFOTAXIME ARE SIMILARLY EFFECTIVE IN PEDIATRIC PNEUMONIA [PDF]
Pneumonia is an infection of the lungs that occurs and still cause high mortality in young children today. The main cause is bacterial or viral. Antibiotics still recommended though it is difficult to know the cause is bacterial or viral.
Didik Hasmono +2 more
core +1 more source
The therapeutic potential of amoxicillin plus sulbactam and its effect on dynamics of milk leukocytes in bovine sub clinical mastitis were investigated in this study.
U.K. De, R. Mukherjee
doaj +1 more source
Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscess [PDF]
BACKGROUND: Aspiration pneumonia (AP) and primary lung abscess (PLA), are diseases following aspiration of infectious material from the oropharynx or stomach. An antibiotic therapy, also covering anaerobic pathogens, is the treatment of choice.
Lode, H +4 more
core +1 more source
Sulbactam for carbapenem-resistant Acinetobacter baumannii infections: a literature review [PDF]
Carbapenem-resistant Acinetobacter baumannii (CRAB) is characterized as a critical priority pathogen with restricted therapeutic options. To date, the most effective antimicrobial treatment against this difficult-to-treat bacterial strain has not been ...
Agouridis, Aris P +5 more
core
Background: Although antibiotic resistance is a well-known issue in veterinary medicine, studies proposing real-time therapeutic monitoring (TDM) are lacking. The objective of the present study was to develop a simple and rapid protocol for the real-time
Anisa Bardhi +4 more
doaj +1 more source
Background: Beta-lactamase inhibitors (BLIs) are widely used with beta-lactam antibiotics to combat resistant infections, yet their safety profiles, especially for newer agents, remain underexplored.
Kannan Sridharan, Gowri Sivaramakrishnan
doaj +1 more source
Background/Objectives: Extended-spectrum β-lactamase (ESBL)-producing Escherichia coli poses a significant global health challenge, as it leads to antimicrobial treatment failure and is associated with elevated mortality rates.
Ru Wang +8 more
doaj +1 more source
Extensively drug-resistant (XDR) Acinetobacter baumannii infection has significant challenges due to limited treatment options. Although sulbactam (SUL) shows in vitro effectiveness against XDR A. baumannii, the efficacy of SUL-based combinations remains
Anupop Jitmuang +3 more
doaj +1 more source
Effect of ampicillin and sulbactam/ampicillin on the immunesystem [PDF]
An investigation was carried out into the possible effects of ampicillin and a sulbactam/ampicillin combination on the immune system of healthy subjects.
M.R. Gismondo, A. M. Lo Bue, G. Chisari
core

